重症急性胆管炎32例临床分析  

Clinical analysis of 32 cases of severe acute cholangitis

作　　者：王家文[1] 钱小星[1] 

机构地区：[1]安徽省合肥市第二人民医院,安徽合肥230011

出　　处：《河北医学》2004年第11期1010-1011,共2页Hebei Medicine

摘　　要：目的 :探讨重症急性胆管炎 (ACST)的诊断和治疗方法。方法 :回顾性分析 3 2例ACST病人的治疗情况。结果 :死亡 4例 ,其中手术治疗死亡 2例。早期大剂量应用地塞米松治疗的病人休克得到纠正 ( 80 %、8/ 1 0 ) ,明显高于未用地塞米松的病人 ( 5 0 %、4 / 8)。结论 :ACST病人应尽早手术 ,应早期大剂量应用地塞米松治疗ACST。Objective: To explore the effecfive therapeutic measure for severe acute cholangitis (ACST). Method: Retrospective analysis was made on the treatment and prognosis of 32 patients with ACST. Result: Of 32 patients. 6 died with death rate of 18.8%. There are 4 died from surgical management. Of 10 patients treated with dexamethasone, there are 8 patients whose shocks were corrected, while of 8 patients who were not treated with dexamefhasone. Only 4 patients were recovered. Conclusion: Surgical treatment should be done in the early stage. Dexamethasone should be used for fhe patients with ACST.

关 键 词：ACST 病人 治疗 重症急性胆管炎 地塞米松 大剂量 早期 

分 类 号：R657.45[医药卫生—外科学] R735.7[医药卫生—临床医学]